+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Roche Holding AG - Enterprise Tech Ecosystem Series

Roche Holding AG - Enterprise Tech Ecosystem Series


Roche joined forces with GE Healthcare to combine both companies' capabilities and leverage big data, machine learning, genomics, and imaging technologies to develop decision support tools for clinicians, and help them take data-driven and personalized decisions at each stage of patients' diseases.

In 2013, Roche and California Institute for Quantitative Biosciences (QB3) formed a strategic alliance to create a venture arm, Mission Bay Capital, in order to identify, support, and invest in early stage start-ups focusing on life science, and explore potential opportunities in emerging technologies.

In 2020, Roche launched a National Artificial Intelligence Centre of Excellence in Canada with the vision to launch AI-based solutions that optimize and shrink the cost of healthcare delivery and improve health outcomes.

In April 2020, Roche formed a Data Science Coalition platform to address the challenges posed by SARS-CoV-2 (COVID-19) pandemic.

The report provides information and insights into Roche's tech activities, including:
  • Insights of its digital transformation strategies and innovation programs
  • Overview of technology initiatives covering partnerships, product launches, investments and acquisitions
  • Insights on each technology initiative including technology theme, objective, and benefits
  • Details of estimated ICT budgets and major ICT contracts

  • Roche is tapping key disruptive technologies to reduce time-to-market capabilities, and develop innovative products that can help provide advanced healthcare solutions to patients, and improve customer engagement. Artificial intelligence, big data, biotechnology, blockchain, analytics, cloud, robotic process automation, 3D printing, mobile, and genomics are the key technologies under focus for the company.
  • Roche is embarking on its digital transformation journey through innovations, research and development centers, and technology acquisitions, in order to bring innovative products and solutions for its customers.
  • Roche Diagnostics collaborated with Microsoft and Cleidon to tap into IoT and cloud computing technologies, and transform their healthcare product and services portfolio related to in vitro diagnostic (IVD) devices, and to offer patients with better healthcare solutions.
  • Roche has setup an global hub and created a big-data ecosystem equipped with necessary digital and IT infrastructure, which acts as a comprehensive diabetes management platform.

Reasons to Buy
  • Gain insights into Roche's tech operations.
  • Gain insights into its tech strategies and innovation initiatives.
  • Gain insights into its technology themes under focus.
  • Gain insights into various product launches, partnerships, investments and acquisition strategies of Roche.

Table of Contents

  • Overview
  • Digital Transformation Strategy
  • Accelerator/Incubator & Other Innovation Programs
  • Technology Focus
  • Technology Initiatives
  • Investments
  • Acquisitions
  • Partnership, Investment & Acquisition Network Map
  • ICT Budgets & Contracts
  • Key Executives
  • About the Publisher

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • PicnicHealth
  • ZappRx
  • GE Healthcare
  • Alcyone Lifesciences
  • Organovo
  • Ocean Protocol
  • Aligos
  • Jasper Therapeutics
  • Black Diamond Therapeutics
  • Purigen Biosystems
  • MacuLogix
  • Minoryx Therapeutics
  • Ideaya Biosciences
  • NMD Pharma
  • Pandion Therapeutics
  • Vivet Therapeutics
  • Lumos Pharma
  • Mission Therapeutics
  • Biodesy
  • Viewics
  • Syapse
  • Omicia
  • Freenome
  • Second Genome
  • Flatiron Health
  • Carbon Health
  • Spark Therapeutics
  • Promedior
  • ForSight VISION4
  • mySugr
  • Diabeloop
  • Sensyne Health
  • Veeva Systems